MELVILLE, N.Y.--(BUSINESS WIRE)--Bovie Medical Corporation (the “Company”) (Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced its financial results for the third quarter and nine months ended September 30, 2007. Revenues for the third quarter increased 6.6% to a record $7.5 million versus $7.0 million recorded for the third quarter 2006. Net income for the third quarter was $471,636 or $.03 per diluted share on 17,699,654 weighted average shares fully diluted compared to $856,959 or $.05 per diluted share on 17,483,781 weighted average shares fully diluted for the comparable period last year. Income before minority interest and income tax for the third quarter of 2007 was $744,917 compared to $859,526 in 2006. The decline resulted from increased research and development expenses of approximately $155,000 related to new product development, as increases in other expenses were offset by increased gross profit.
